There were many small cap stocks which managed to record meaningful gains last week and one of those was the Enzolytics Inc (OTCMKTS:ENZC) stock, which managed to clock gains of 7%.
The micro cap stock has attracted a lot of investors and it seems that they are determined to send it to multiple dollar levels in the near future. In this sort of a situation, it might be a good move for investors to keep a close eye on the stock. In this regard, it should be noted that the stock has got a lot of attention from investors ever since the company had its merger with BioClonetics.
In this regard, it is also necessary to keep in mind that the new merged entity is also involved in a lot of important projects that have excited investors considerably. Enzolytics is currently involved in the production of fully human monoclonal antibodies meant for the purpose of treating COVID 19 infection and also for treating AIDS. These two projects have brought considerable attention to the Enzolytics stock and it might be a good move for investors to keep a close eye on all the developments on this particular front over the coming months.
On Friday, ENZC stock gained 7.20% at $0.2015 with more than 18.11 million shares, compared to its average volume of 39.41 million shares. The stock has moved within a range of $0.1780 – 0.2070 after opening the trade at $0.20. Over the past 52-week, the stock has been trading within a range of $0.0003 – 0.9580.